WILCO Automates High-Mix/Low-Volume Visual Inspection with the launch of EVO CAX
Designed for visual
inspection of high-mix/low-volume pharmaceutical products, the EVO CAX 20 fully
automates vial inspection within the smallest possible footprint. This
innovative solution enhances production planning flexibility, particularly in
clinical and small-scale environments, by providing consistent, high-quality
visual inspection.
The EVO CAX addresses longstanding challenges faced by pharmaceutical manufacturers in
high-mix, low-volume production settings. Clinical and small-scale production
requires high flexibility for product turnover while the intervals between
batches can be difficult to bridge for human operators. The EVO CAX delivers 100%
automated visual inspection efficiency with reliable and reproducible results at
minimal space requirements. It’s an ideal solution for facilities constrained
by space, suitable for both clinical and small-scale production environments.
Key Features
1. Small Footprint
Designed for minimal space, the EVO CAX seamlessly
integrates into existing production environments. Its ideal size allows for
scalability through a fleet concept as well as accompanying a product
throughout its life cycle, from the laboratory to inline production through to
reduced product volume before market withdrawal.
2. Quick Format Change
Featuring the WILCO OptiX fixed vision system, the EVO
CAX eliminates the need for setup adjustments during format changes, enhancing
operational efficiency.
3. Highest Flexibility
Capable of handling liquid and lyophilized (lyo) vials
ranging from 2R to 30R at speeds up to 20 vials per minute, the EVO CAX
supports swift product changes.
4.
Fast
Recipe Development Cycles
Equipped with AI-supported baselines, the EVO CAX
accelerates the development and validation of new product recipes, ensuring
rapid adaptation to varying production configurations.
Addressing Market
Challenges
The clinical production
of parenterals often encounters issues such as product variability, infrequent
production batches, and small batch sizes. Manual Visual Inspection (MVI)
requires extensive operator training and requalification, resulting in
fluctuating inspection quality. The EVO CAX overcomes these challenges by
consistently delivering high-quality inspection results during production runs
spread over time, reducing the need for constant requalification and enabling
economical production of small batches.
Innovative Design for High
Performance
The
EVO CAX is compact in size, but does not hold back on additional innovations
and functionalities to improve inspection quality and usability while focusing
on gentle products treatment:
-
Adapted
Lighting:
Reduced energy exposure to products, minimizing stress and preserving product
integrity.
-
Human-Inspired
Inspection: Gentle
mechanical handling with robots reduces the need for fast vial spinning,
further protecting products.
-
Turbidity
and Color Inspection: Fully
integrated color and turbidity measurement for less stress on products by
reducing transport needs.
-
Operator
Assistance:
Guides operators through critical processes, such as line clearance, ensuring
smooth and error-free operation.
-
Image
Quality:
Highest resolution lowers false rejects and allows additional inspection tasks.
The EVO CAX sets a new
benchmark for visual inspection, delivering reproducibility, security, and
stringent quality standards. Its advanced capabilities cater to the evolving
needs of ATMP (Advanced Therapy Medicinal Products) and C&G (Cell &
Gene) product markets, offering a reliable alternative to manual inspection
methods.
Joint Development and
Market Launch
The EVO CAX is the
result of a successful collaboration between WILCO AG and a major
pharmaceutical company. Following an intensive, three-year development phase,
the EVO CAX is now ready for its official market launch. Detailed information
and product specifications will be available on the WILCO AG website at
https://www.wilco.com/products/.